메뉴 건너뛰기




Volumn 62, Issue 2, 1996, Pages 282-291

Sensitization of human ovarian tumor cells by subtoxic CDDP to anti- Fas antibody-mediated cytotoxicity and apoptosis

Author keywords

[No Author keywords available]

Indexed keywords

BUTYLATED HYDROXYANISOLE; CISPLATIN; DNA FRAGMENT; FAS ANTIGEN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

EID: 0030220139     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0228     Document Type: Article
Times cited : (44)

References (43)
  • 1
    • 0023684531 scopus 로고
    • Phase 1 trial of intravenously administered recombinant tumor necrosis factor-alpha in cancer patients
    • 1. Feinberg, B., Kurzurock, R., Talpaz, M., Blick, M., Saks, S., and Gutterman, J. U. Phase 1 trial of intravenously administered recombinant tumor necrosis factor-alpha in cancer patients, J. Clin. Oncol. 6, 1328-1332 (1992).
    • (1992) J. Clin. Oncol. , vol.6 , pp. 1328-1332
    • Feinberg, B.1    Kurzurock, R.2    Talpaz, M.3    Blick, M.4    Saks, S.5    Gutterman, J.U.6
  • 2
    • 0026813323 scopus 로고
    • The immunotherapy and gene therapy of cancer
    • 2. Rosenberg, S. A. The immunotherapy and gene therapy of cancer, J. Clin. Oncol. 10, 180-199 (1992).
    • (1992) J. Clin. Oncol. , vol.10 , pp. 180-199
    • Rosenberg, S.A.1
  • 5
    • 0026556005 scopus 로고
    • Hierarchy of sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs, and toxins
    • 5. Safrit, J., Tsuchitani, T., Zighelboim, J., and Bonavida, B. Hierarchy of sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs, and toxins, Cancer Immunol. Immunother. 34, 321-328 (1992).
    • (1992) Cancer Immunol. Immunother. , vol.34 , pp. 321-328
    • Safrit, J.1    Tsuchitani, T.2    Zighelboim, J.3    Bonavida, B.4
  • 6
    • 0027232299 scopus 로고
    • Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-fas antibody and drugs or toxins
    • 6. Morimoto, H., Yonehara, S., and Bonavida, B. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins, Cancer Res. 53, 2591-2596 (1993).
    • (1993) Cancer Res. , vol.53 , pp. 2591-2596
    • Morimoto, H.1    Yonehara, S.2    Bonavida, B.3
  • 7
    • 0024390026 scopus 로고
    • Augmentation of antitumor efficacy by the combination of tumor necrosis factor and chemotherapeutic agents in vivo
    • 7. Krosnick, J. A., Mule, J. J., McIntosh, J. K., and Rosenberg, S. A. Augmentation of antitumor efficacy by the combination of tumor necrosis factor and chemotherapeutic agents in vivo, Cancer Res. 49, 3729-3733 (1989).
    • (1989) Cancer Res. , vol.49 , pp. 3729-3733
    • Krosnick, J.A.1    Mule, J.J.2    McIntosh, J.K.3    Rosenberg, S.A.4
  • 8
    • 0027236106 scopus 로고
    • Overcoming cis-diamminedichloroplatinum II resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum II and TNF-α
    • 8. Mizutani, Y., and Bonavida, B. Overcoming cis-diamminedichloroplatinum II resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum II and TNF-α, Cancer 72, 809-818 (1993).
    • (1993) Cancer , vol.72 , pp. 809-818
    • Mizutani, Y.1    Bonavida, B.2
  • 9
    • 0027209190 scopus 로고
    • Overcoming TNF-α and CDDP resistance of a human ovarian cancer cell line (C30) by treatment with buthionine sulfoximine in combination with TNF-α and/or CDDP
    • 9. Mizutani, Y., and Bonavida, B. Overcoming TNF-α and CDDP resistance of a human ovarian cancer cell line (C30) by treatment with buthionine sulfoximine in combination with TNF-α and/or CDDP, Int. J. Oncol. 3, 229-235 (1993).
    • (1993) Int. J. Oncol. , vol.3 , pp. 229-235
    • Mizutani, Y.1    Bonavida, B.2
  • 10
    • 0030021993 scopus 로고    scopus 로고
    • Role of free radicals in the synergy achieved by treatment with both TNF-α and CDDP on human ovarian carcinoma cells
    • 10. Uslu, R., and Bonavida, B. Role of free radicals in the synergy achieved by treatment with both TNF-α and CDDP on human ovarian carcinoma cells, Cancer 77, 725-732 (1996).
    • (1996) Cancer , vol.77 , pp. 725-732
    • Uslu, R.1    Bonavida, B.2
  • 11
    • 0006751498 scopus 로고
    • Immunosupressive agents
    • (A. C. Sartorelli and D. G. Johns, Eds.), Springer-Verlag, New York
    • 11. Hersh, E. M. Immunosupressive agents, in Antineoplastic and immunosupressive agents I (A. C. Sartorelli and D. G. Johns, Eds.), Springer-Verlag, New York, pp. 557-617 (1974).
    • (1974) Antineoplastic and Immunosupressive Agents I , pp. 557-617
    • Hersh, E.M.1
  • 12
    • 0011876855 scopus 로고
    • Immunoregulation by cancer chemotherapeutic agents
    • (J. W. Hadder and A. Szentivanyi, Eds.), Plenum, New York
    • 12. Ehrke, M. J., and Mihich, E. Immunoregulation by cancer chemotherapeutic agents, in The reticuloendothelial system: A comprehensive treatise (J. W. Hadder and A. Szentivanyi, Eds.), Plenum, New York, pp. 309-347 (1985).
    • (1985) The Reticuloendothelial System: A Comprehensive Treatise , pp. 309-347
    • Ehrke, M.J.1    Mihich, E.2
  • 13
    • 0018070027 scopus 로고
    • Effect of chemotherapeutic agents on natural cell-mediated cytotoxicity in mice
    • 13. Montavani, A., Luini, W., Vecchi, A., and Spreafico, F. Effect of chemotherapeutic agents on natural cell-mediated cytotoxicity in mice, J. Natl. Cancer Inst. 61, 1255-1258 (1978).
    • (1978) J. Natl. Cancer Inst. , vol.61 , pp. 1255-1258
    • Montavani, A.1    Luini, W.2    Vecchi, A.3    Spreafico, F.4
  • 14
    • 0020446174 scopus 로고
    • Augmentation of the human immune response by cyclophosphamide
    • 14. Berd, D., Mastrangelo, M., Engstrom, P., Paul, A., and Maguire, H. Augmentation of the human immune response by cyclophosphamide, Cancer Res. 42, 4862-4867 (1982).
    • (1982) Cancer Res. , vol.42 , pp. 4862-4867
    • Berd, D.1    Mastrangelo, M.2    Engstrom, P.3    Paul, A.4    Maguire, H.5
  • 15
    • 0014691619 scopus 로고
    • Platinum compounds: A new class of potent antitumor agents
    • 15. Rosenberg, B., Van Camp, L., Trosko, J. E., and Mansour, V. H. Platinum compounds: A new class of potent antitumor agents, Nature 222, 285-286 (1969).
    • (1969) Nature , vol.222 , pp. 285-286
    • Rosenberg, B.1    Van Camp, L.2    Trosko, J.E.3    Mansour, V.H.4
  • 16
    • 0021435857 scopus 로고
    • Drugs five years later. Cisplatin
    • 16. Loehrer, P. J., and Einhorn, L. H. Drugs five years later. Cisplatin, Ann. Intern. Med. 100, 704-713 (1984).
    • (1984) Ann. Intern. Med. , vol.100 , pp. 704-713
    • Loehrer, P.J.1    Einhorn, L.H.2
  • 17
    • 0016373567 scopus 로고
    • Interaction between mammalian cell DNA and inorganic platinum compounds I. DNA interstrand cross-linking and cytotoxic properties of platinum II compounds
    • 17. Pascoe, J. M., and Roberts, J. J. Interaction between mammalian cell DNA and inorganic platinum compounds I. DNA interstrand cross-linking and cytotoxic properties of platinum II compounds, Biochem. Pharmacol. 23, 1345-1357 (1974).
    • (1974) Biochem. Pharmacol. , vol.23 , pp. 1345-1357
    • Pascoe, J.M.1    Roberts, J.J.2
  • 18
    • 0016945130 scopus 로고
    • Effects of cis-dichlorodiammineplatinum (II) on DNA synthesis in kidney and other tissues of normal and tumor-bearing rats
    • 18. Taylor, D. M., Tew, K. D., and Jones, J. D. Effects of cis-dichlorodiammineplatinum (II) on DNA synthesis in kidney and other tissues of normal and tumor-bearing rats, Eur. J. Cancer 12, 249-254 (1976).
    • (1976) Eur. J. Cancer , vol.12 , pp. 249-254
    • Taylor, D.M.1    Tew, K.D.2    Jones, J.D.3
  • 19
    • 0023720156 scopus 로고    scopus 로고
    • Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney kortex: Different effect of antioxidants and radical scavengers
    • 19. Hannemann, J., and Baumann, K. Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney kortex: Different effect of antioxidants and radical scavengers, Toxicology 51, 119-132.
    • Toxicology , vol.51 , pp. 119-132
    • Hannemann, J.1    Baumann, K.2
  • 20
    • 0027965261 scopus 로고
    • Cisplatin generates superoxide anion by intercalation with DNA in a cell free system
    • 20. Masuda, H., Tanaka, T., and Takahama, U. Cisplatin generates superoxide anion by intercalation with DNA in a cell free system, Biochem. Biophys. Res. Commun. 203, 1175-1180 (1994).
    • (1994) Biochem. Biophys. Res. Commun. , vol.203 , pp. 1175-1180
    • Masuda, H.1    Tanaka, T.2    Takahama, U.3
  • 21
    • 0028905096 scopus 로고
    • Free radicals dependent and independent pathways of CDDP-mediated cytotoxicity and apoptosis in ovarian tumor cell lines
    • 21. Uslu, R., and Bonavida, B. Free radicals dependent and independent pathways of CDDP-mediated cytotoxicity and apoptosis in ovarian tumor cell lines, Int. J. Oncol. 6, 1003-1009 (1995).
    • (1995) Int. J. Oncol. , vol.6 , pp. 1003-1009
    • Uslu, R.1    Bonavida, B.2
  • 22
    • 0018956422 scopus 로고
    • Enhancement of naturally occurring human spontaneous monocyte-mediated cytotoxicity by cis-diamminedichloroplatinum (II)
    • 22. Kleinerman, E. S., Zwelling, L. A., and Mushmore, A. V. Enhancement of naturally occurring human spontaneous monocyte-mediated cytotoxicity by cis-diamminedichloroplatinum (II), Cancer Res. 40, 3099-3102 (1980).
    • (1980) Cancer Res. , vol.40 , pp. 3099-3102
    • Kleinerman, E.S.1    Zwelling, L.A.2    Mushmore, A.V.3
  • 23
    • 0022640565 scopus 로고
    • Enhancement of natural killer cytotoxicity by cis-diamminedichloroplatinum (II) in vivo and in vitro
    • 23. Lichenstein, A. K., and Pende, D. Enhancement of natural killer cytotoxicity by cis-diamminedichloroplatinum (II) in vivo and in vitro, Cancer Res. 46, 639-644 (1985).
    • (1985) Cancer Res. , vol.46 , pp. 639-644
    • Lichenstein, A.K.1    Pende, D.2
  • 24
    • 0025572458 scopus 로고
    • Activation of human natural killer cells and monocytes with cisplatin in vitro
    • 24. Sohdi, A., Pai, K., Singh, R. K., and Singh, S. M. Activation of human natural killer cells and monocytes with cisplatin in vitro, Int. J. Immunopharmacol. 12, 893-898 (1990).
    • (1990) Int. J. Immunopharmacol. , vol.12 , pp. 893-898
    • Sohdi, A.1    Pai, K.2    Singh, R.K.3    Singh, S.M.4
  • 25
    • 0027446372 scopus 로고    scopus 로고
    • Enhanced susceptibility of CDDP-treateated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells
    • 25. Mizutani, Y., Bonavida, B., Nio, Y., and Yoshida, O. Enhanced susceptibility of CDDP-treateated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells, Cancer 71, 1313-1321.
    • Cancer , vol.71 , pp. 1313-1321
    • Mizutani, Y.1    Bonavida, B.2    Nio, Y.3    Yoshida, O.4
  • 26
    • 0026714608 scopus 로고
    • Activation of human peripheral blood monocytes by CDDP: Enhanced tumoricidal activity and secretion of TNF-α
    • 26. Gan, X. H., Jewett, A., and Bonavida, B. Activation of human peripheral blood monocytes by CDDP: Enhanced tumoricidal activity and secretion of TNF-α, Nat. Immun. 11, 144-155 (1992).
    • (1992) Nat. Immun. , vol.11 , pp. 144-155
    • Gan, X.H.1    Jewett, A.2    Bonavida, B.3
  • 27
    • 0028671833 scopus 로고
    • Fas and Fas ligand: A death factor and its receptor
    • 27. Nagata, S. Fas and Fas ligand: A death factor and its receptor. Adv. Immunol. 57, 129-144 (1994).
    • (1994) Adv. Immunol. , vol.57 , pp. 129-144
    • Nagata, S.1
  • 29
    • 0024596722 scopus 로고
    • A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor
    • 29. Yonehara, S., Ishii, A., and Yonehara, M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor, J. Exp. Med. 169, 1747-1756 (1989).
    • (1989) J. Exp. Med. , vol.169 , pp. 1747-1756
    • Yonehara, S.1    Ishii, A.2    Yonehara, M.3
  • 32
    • 0026568919 scopus 로고
    • Lymphoproliferation disorder in mice explained by defects in fas antigen that mediates apoptosis
    • 32. Watanabe-Fukanaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., and Nagata, S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis, Nature (London) 356, 314-317 (1992).
    • (1992) Nature (London) , vol.356 , pp. 314-317
    • Watanabe-Fukanaga, R.1    Brannan, C.I.2    Copeland, N.G.3    Jenkins, N.A.4    Nagata, S.5
  • 33
    • 0027145632 scopus 로고
    • Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
    • 33. Suda, T., Takahashi, T., Golstein, P., and Nagata, S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family, Cell 75, 1169-1178 (1993).
    • (1993) Cell , vol.75 , pp. 1169-1178
    • Suda, T.1    Takahashi, T.2    Golstein, P.3    Nagata, S.4
  • 37
    • 0028962125 scopus 로고
    • Fas-mediated cytotoxicity by freshly isolated natural killer cells
    • 37. Arase, H., Arasi, N., and Saito, T. Fas-mediated cytotoxicity by freshly isolated natural killer cells, J. Exp. Med. 181, 1235-1238 (1995).
    • (1995) J. Exp. Med. , vol.181 , pp. 1235-1238
    • Arase, H.1    Arasi, N.2    Saito, T.3
  • 38
    • 0028357173 scopus 로고
    • Rapid quantation of apoptosis in pure and heterogenous cell populations using flow cytometry
    • 38. Telford, W. G., King, L. E., and Fraker, P. J. Rapid quantation of apoptosis in pure and heterogenous cell populations using flow cytometry, J. Immunol. Methods 172, 1-16 (1994).
    • (1994) J. Immunol. Methods , vol.172 , pp. 1-16
    • Telford, W.G.1    King, L.E.2    Fraker, P.J.3
  • 40
    • 0019750732 scopus 로고
    • Criterion for analyzing interactions between biologically active agents
    • 40. Berenbaum, M. C. Criterion for analyzing interactions between biologically active agents, Adv. Cancer Res. 35, 269-290 (1981).
    • (1981) Adv. Cancer Res. , vol.35 , pp. 269-290
    • Berenbaum, M.C.1
  • 41
    • 0024428198 scopus 로고
    • Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor
    • 41. Wong, G. H. W., Elwell, J. H., Oberly, L. W., and Goeddel, D. V. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor, Cell 58, 923-931 (1989).
    • (1989) Cell , vol.58 , pp. 923-931
    • Wong, G.H.W.1    Elwell, J.H.2    Oberly, L.W.3    Goeddel, D.V.4
  • 42
    • 0028287963 scopus 로고
    • Fas and tumor necrosis factor receptor-mediated cell death: Similarities and distinctions
    • 42. Clement, M. V., and Stamenkovic, I. Fas and tumor necrosis factor receptor-mediated cell death: Similarities and distinctions, J. Exp. Med. 180, 557-567 (1994).
    • (1994) J. Exp. Med. , vol.180 , pp. 557-567
    • Clement, M.V.1    Stamenkovic, I.2
  • 43
    • 0027994239 scopus 로고
    • Cell nucleus and DNA fragmentation are not required for apoptosis
    • 43. Schulze-Osthoff, K., Walczak, H., Droge, W., and Krammer, P. H. Cell nucleus and DNA fragmentation are not required for apoptosis, J. Cell Biol. 127, 15-20 (1994).
    • (1994) J. Cell Biol. , vol.127 , pp. 15-20
    • Schulze-Osthoff, K.1    Walczak, H.2    Droge, W.3    Krammer, P.H.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.